PND32 COST-EFECTIVENESS AND BUDGET IMPACT OF VAGUS NERVE STIMULATION WITH ASPIRE SR MODEL 106 COMPARED TO ANTI-EPILEPTIC DRUGS IN A SUBGROUP OF PATIENTS WITH DRUG RESISTANT EPILEPSY IN PUBLIC SETTING IN TURKEY

Nov 1, 2019, 00:00
10.1016/j.jval.2019.09.1802
https://www.valueinhealthjournal.com/article/S1098-3015(19)34180-4/fulltext
Title : PND32 COST-EFECTIVENESS AND BUDGET IMPACT OF VAGUS NERVE STIMULATION WITH ASPIRE SR MODEL 106 COMPARED TO ANTI-EPILEPTIC DRUGS IN A SUBGROUP OF PATIENTS WITH DRUG RESISTANT EPILEPSY IN PUBLIC SETTING IN TURKEY
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(19)34180-4&doi=10.1016/j.jval.2019.09.1802
First page :
Section Title :
Open access? : No
Section Order : 11566
Categories :
Tags :
Regions :
ViH Article Tags :